Globavend Holdings Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Globavend Holdings Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	13.3	24	18.6	16.5	23.6
Cost of revenue	12.3	22.6	16.7	14.1	21.2
Gross profit	0.98	1.41	1.91	2.42	2.38
General and administrative	0.42	0.59	0.76	1.08	1.42
Operating expenses	0.42	0.59	0.76	1.08	1.42
Operating income	0.56	0.82	1.15	1.34	0.96
Interest expense	0	0	0	0	0
Interest income			0	0.07	0.06
Other non-operating income	0.08	0.12	0.12	0.22	-0.07
Pre-tax income	0.64	0.94	1.27	1.56	0.88
Income tax	0.08	0.13	0.19	0.22	0.2
Net income	0.56	0.81	1.08	1.34	0.68
EBITDA	0.56	0.82	1.15	1.36	1.03
EPS, basic	8.21	12.32	16.42	18.39	1.61
EPS, diluted	8.21	12.32	16.42	18.39	1.61
Shares, basic (weighted)	0.06	0.06	0.07	0.07	0.42
Shares, diluted (weighted)	0.06	0.06	0.07	0.07	0.42

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents		0.56	0.55	2.3	7.51
Receivables		1.11	1.43	1.68	1
Other current assets			0.17
Total current assets		2.12	4.02	5.46	9.96
Property, plant and equipment		0.01	0.01	0.12	0.05
Lease right-of-use assets		0.07	0.12	0.03	0.03
Total assets		2.52	4.47	7.96	11.2
Accounts payable		0.01	1.1	0.65	0.75
Deferred revenue					0.01
Total current liabilities		1.62	3.89	2.79	1.18
Lease liabilities		0	0.08
Total liabilities		1.62	3.97	2.79	1.18
Paid-in capital		0.13	0.13	3.45	7.35
Retained earnings		0.77	0.37	1.71	2.4
Other comprehensive income					0
Shareholders' equity	1.56	0.9	0.5	5.17	10
Total equity	1.56	0.9	0.5	5.17	10
Total liabilities and equity		2.52	4.47	7.96	11.2
Shares outstanding	0.06	0.06	13.1	0.07	1.53

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	0.56	0.81	1.08	1.34	0.68
Depreciation and amortization	0	0	0	0.02	0.07
Stock-based compensation					0.04
Change in receivables	-0.04	-0.29	-0.35	-0.26	0.7
Cash from operations	0.88	0.78	2.02	0.33	0.24
Capital expenditures	-0	-0.01	-0.01	-0.59	-0.01
Cash from investing	-0	-0.01	-0.01	-0.59	-0.01
Stock issued				5.38	13.5
Dividends paid		-1.24	-1.47
Cash from financing	-0.22	-1.24	-2.02	2.01	4.98
Net change in cash	0.65	-0.47	-0	1.74	5.21
Free cash flow	0.87	0.77	2.01	-0.27	0.23
Income taxes paid	-0.03	-0.14	0.09	0.15	0.51

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.08 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	10.1%	Gross profit / revenue.
Operating margin	4.1%	Operating income / revenue.
EBITDA margin	4.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.7%	Pre-tax income / revenue.
Net margin	2.9%	Net income / revenue.
FCF margin	1.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.0%	Cash from operations / revenue.
Effective tax rate	22.7%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.1%	Net income / average total assets.
Return on invested capital (ROIC)	27.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.0%	Capital expenditures / revenue.
D&A / revenue	0.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	42.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	-1.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	19.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	-28.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	5.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-24.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	7.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-49.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-5.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-91.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-49.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-26.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-32.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-33.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	94.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	123.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	41.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	64.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	481.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	87.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	8.46x	Current assets / current liabilities.
Quick ratio	7.23x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	6.38x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	10.5%	Total liabilities / total assets.
Interest coverage	963x	Operating income / interest expense.
Working capital	$8.8M	Current assets - current liabilities.
Tangible book value	$10.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.46x	Revenue / average total assets.
Fixed asset turnover	267x	Revenue / average property, plant and equipment.
Receivables turnover	17.5x	Revenue / average receivables.
Days sales outstanding	21 days	365 x average receivables / revenue.
Days payables	12 days	365 x average accounts payable / cost of revenue.
FCF conversion	34.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	3.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.61	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$1.61	Net income per basic share, as reported (split-adjusted).
Revenue per share	$55.69	Revenue / diluted weighted shares.
FCF per share	$0.55	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.57	Cash from operations / diluted weighted shares.
Book value per share	$6.58	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.58	Tangible book value / shares outstanding.
Cash per share	$4.92	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$4.6M	Share price x shares outstanding.
Enterprise value	-$2.9M	Market cap + total debt - cash - short-term investments.
P/E	6.81x	Market cap / net income. Only when net income is positive.
P/S	0.20x	Market cap / revenue.
P/B	0.46x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.46x	Market cap / tangible book value, when positive.
P/FCF	20.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	19.3x	Market cap / cash from operations, when positive.
FCF yield	5.0%	Free cash flow / market cap.
Earnings yield	14.7%	Net income / market cap (the inverse of P/E).

What was Globavend Holdings Ltd's revenue in fiscal 2025?

Globavend Holdings Ltd reported revenue of $23.6M for fiscal 2025, 42.5% higher than the year before.

Was Globavend Holdings Ltd profitable in fiscal 2025?

Yes. Net income was $683.0K, a net margin of 2.9%.

How much free cash flow did Globavend Holdings Ltd generate in fiscal 2025?

Cash from operations of $240.4K minus capital expenditures of $8.3K left free cash flow of $232.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Globavend Holdings Ltd